Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    December 2017
  1. YUAN X, Lin H, Li B, He K, et al
    Efficacy and immunogenicity of recombinant swinepox virus expressing the truncated S protein of a novel isolate of porcine epidemic diarrhea virus.
    Arch Virol. 2017;162:3779-3789.
    PubMed     Text format     Abstract available


  2. ZAIDI SSZ, Hameed A, Ali N, Umair M, et al
    A measles outbreak in Sindh, Pakistan caused by a genotype B3 virus.
    Arch Virol. 2017;162:3603-3610.
    PubMed     Text format     Abstract available


    November 2017
  3. BAGHBAN RAHIMI S, Mohebbi A, Vakilzadeh G, Biglari P, et al
    Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Arch Virol. 2017 Nov 17. doi: 10.1007/s00705-017-3647.
    PubMed     Text format     Abstract available


    October 2017
  4. KRISHNAVAJHALA HR, Williams J, Heidner H
    An influenza A virus vaccine based on an M2e-modified alphavirus.
    Arch Virol. 2017 Oct 27. doi: 10.1007/s00705-017-3578.
    PubMed     Text format     Abstract available


    September 2017
  5. TURMAGAMBETOVA AS, Alexyuk PG, Bogoyavlenskiy AP, Zaitseva IA, et al
    Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine.
    Arch Virol. 2017 Sep 21. doi: 10.1007/s00705-017-3560.
    PubMed     Text format     Abstract available


    August 2017
  6. SONG Y, Fan Z, Zuo Y, Wei H, et al
    Binding of rabbit hemorrhagic disease virus-like particles to host histo-blood group antigens is blocked by antisera from experimentally vaccinated rabbits.
    Arch Virol. 2017 Aug 5. doi: 10.1007/s00705-017-3509.
    PubMed     Text format     Abstract available


  7. ZHUGUNISSOV K, Bulatov Y, Taranov D, Yershebulov Z, et al
    Protective immune response of oral rabies vaccine in stray dogs, corsacs and steppe wolves after a single immunization.
    Arch Virol. 2017 Aug 1. doi: 10.1007/s00705-017-3499.
    PubMed     Text format     Abstract available


    July 2017
  8. ORABI A, Hussein A, Saleh AA, El-Magd MA, et al
    Evolutionary insights into the fusion protein of Newcastle disease virus isolated from vaccinated chickens in 2016 in Egypt.
    Arch Virol. 2017 Jul 8. doi: 10.1007/s00705-017-3483.
    PubMed     Text format     Abstract available


    June 2017
  9. FENG S, Wang C, Hu S, Wu Q, et al
    Recent progress in the development of white spot syndrome virus vaccines for protecting shrimp against viral infection.
    Arch Virol. 2017 Jun 24. doi: 10.1007/s00705-017-3450.
    PubMed     Text format     Abstract available


  10. LEITE FGG, Torres AA, De Oliveira LC, Da Cruz AFP, et al
    c-Jun integrates signals from both MEK/ERK and MKK/JNK pathways upon vaccinia virus infection.
    Arch Virol. 2017 Jun 15. doi: 10.1007/s00705-017-3446.
    PubMed     Text format     Abstract available


  11. SHARMA KK, Kalyani IH, Mohapatra J, Patel SD, et al
    Evaluation of the oncolytic potential of R2B Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620).
    Arch Virol. 2017 Jun 3. doi: 10.1007/s00705-017-3411.
    PubMed     Text format     Abstract available


    May 2017
  12. XIAO X, Zhang Y, Wei Q, Yin X, et al
    Flagellin FljB as an adjuvant to the recombinant adenovirus rabies glycoprotein vaccine increases immune responses against rabies in mice.
    Arch Virol. 2017 May 26. doi: 10.1007/s00705-017-3413.
    PubMed     Text format     Abstract available


  13. LEITE FGG, Bergthaler A, Skern T
    Vaccinia virus G1 protein: absence of autocatalytic self-processing.
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3409.
    PubMed     Text format     Abstract available


    April 2017
  14. RODRIGUEZ LAY LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, et al
    Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Arch Virol. 2017 Apr 24. doi: 10.1007/s00705-017-3365.
    PubMed     Text format     Abstract available


  15. VALDES I, Marcos E, Suzarte E, Perez Y, et al
    A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses.
    Arch Virol. 2017 Apr 9. doi: 10.1007/s00705-017-3360.
    PubMed     Text format     Abstract available


  16. COSTA GB, Lavergne A, Darcissac E, Lacoste V, et al
    Absence of vaccinia virus detection in a remote region of the Northern Amazon forests, 2005-2015.
    Arch Virol. 2017 Apr 7. doi: 10.1007/s00705-017-3353.
    PubMed     Text format     Abstract available


  17. YOGISHARADHYA R, Kumar A, Ramappa R, Venkatesan G, et al
    Functional characterization of recombinant major envelope protein (rB2L) of orf virus.
    Arch Virol. 2017;162:953-962.
    PubMed     Text format     Abstract available


    March 2017
  18. SHAH MS, Ashraf A, Khan MI, Rahman M, et al
    Fowl adenovirus: history, emergence, biology and development of a vaccine against hydropericardium syndrome.
    Arch Virol. 2017 Mar 10. doi: 10.1007/s00705-017-3313.
    PubMed     Text format     Abstract available


    February 2017
  19. KWAK BO, Lee HJ, Kang HM, Oh CE, et al
    Genotype analysis of ORF 62 identifies varicella-zoster virus infections caused by a vaccine strain in children.
    Arch Virol. 2017 Feb 15. doi: 10.1007/s00705-017-3276.
    PubMed     Text format     Abstract available


  20. WU W, Liu S, Yu P, Tao X, et al
    Role of systemic injection of rabies immunoglobulin in rabies vaccination.
    Arch Virol. 2017 Feb 10. doi: 10.1007/s00705-017-3263.
    PubMed     Text format     Abstract available


  21. ZHANG M, Ge J, Wen Z, Chen W, et al
    Characterization of a recombinant Newcastle disease virus expressing the glycoprotein of bovine ephemeral fever virus.
    Arch Virol. 2017;162:359-367.
    PubMed     Text format     Abstract available


    January 2017
  22. FOTOUHI F, Shaffifar M, Farahmand B, Shirian S, et al
    Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Arch Virol. 2017 Jan 24. doi: 10.1007/s00705-017-3230.
    PubMed     Text format     Abstract available


    December 2016
  23. ANDOH K, Yamazaki K, Honda Y, Honda T, et al
    Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  24. MOEINI S, Saeidi M, Fotouhi F, Mondanizadeh M, et al
    Erratum to: Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format    


  25. ZHOU Y, Yang X, Wang H, Zeng F, et al
    The establishment and characteristics of cell-adapted IBV strain H120.
    Arch Virol. 2016;161:3179-87.
    PubMed     Text format     Abstract available


    October 2016
  26. ASTRAY RM, Jorge SA, Pereira CA
    Rabies vaccine development by expression of recombinant viral glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  27. LI J, Yu T, Zhang F, Wang X, et al
    Inactivated chimeric porcine circovirus (PCV) 1-2 vaccines based on genotypes 2b and 2d exhibit similar immunological effectiveness in protecting pigs against challenge with PCV2b strain 0233.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  28. MIAO FM, Zhang SF, Wang SC, Liu Y, et al
    Comparison of immune responses to attenuated rabies virus and street virus in mouse brain.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  29. SUN Y, Yang C, Li J, Li L, et al
    Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  30. MOEINI S, Saeidi M, Fotouhi F, Mondanizdeh M, et al
    Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  31. MADAPONG A, Temeeyasen G, Saeng-Chuto K, Tripipat T, et al
    Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  32. AGHASADEGHI MR, Velayati AA, Mamishi S, Nabavi M, et al
    Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  33. ZHU Y, Wang GH, Cui YD, Cui SJ, et al
    Establishment of a nanoparticle-assisted RT-PCR assay to distinguish field strains and attenuated strains of porcine epidemic diarrhea virus.
    Arch Virol. 2016;161:2543-7.
    PubMed     Text format     Abstract available


    July 2016
  34. ANDRADE LG, Albarnaz JD, Mugge FL, David BA, et al
    Vaccinia virus dissemination requires p21-activated kinase 1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  35. SAMY A, El-Enbaawy MI, El-Sanousi AA, Nasef SA, et al
    Initiation and regulation of immune responses to immunization with whole inactivated vaccines prepared from two genetically and antigenically distinct lineages of Egyptian influenza A virus subtype H5N1.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  36. QUINTILIO W, de Freitas FA, Rodriguez D, Kubrusly FS, et al
    Vitamins as influenza vaccine adjuvant components.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  37. NAVID MT, Li Y, Zhou M, Cui M, et al
    Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  38. MENG XY, Luo Y, Liu Y, Shao L, et al
    A triplex real-time PCR for differential detection of classical, variant and Bartha-K61 vaccine strains of pseudorabies virus.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  39. MORIMOTO K, Khawplod P, Sato Y, Virojanapirom P, et al
    Rabies vaccination at a virus-inoculated site as an alternative option to rabies immunoglobulin.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  40. JAGADESH A, Salam AA, Mudgal PP, Arunkumar G, et al
    Influenza virus neuraminidase (NA): a target for antivirals and vaccines.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  41. BALL C, Forrester A, Ganapathy K
    Detection of variant infectious bronchitis viruses in Sri Lanka (2012-2015).
    Arch Virol. 2016;161:1697-9.
    PubMed     Text format     Abstract available


  42. SVIBEN D, Forcic D, Kurtovic T, Halassy B, et al
    Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus.
    Arch Virol. 2016;161:1455-67.
    PubMed     Text format     Abstract available


    March 2016
  43. GE F, Li X, Ju H, Yang D, et al
    Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  44. JIN H, Xia X, Liu B, Fu Y, et al
    High-yield production of canine parvovirus virus-like particles in a baculovirus expression system.
    Arch Virol. 2016;161:705-10.
    PubMed     Text format     Abstract available


    February 2016
  45. TEWAWONG N, Chansaenroj J, Klinfueng S, Vichiwattana P, et al
    Lineage-specific detection of influenza B virus using real-time polymerase chain reaction with melting curve analysis.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  46. CHEN Y, He S, Sun L, Luo Y, et al
    Genetic variation, pathogenicity, and immunogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus strain XH-GD at different passage levels.
    Arch Virol. 2016;161:77-86.
    PubMed     Text format     Abstract available


    September 2015
  47. LEI H, Peng X, Zhao D, Jiao H, et al
    Cross-protection of Lactococcus lactis-displayed HA2 subunit against homologous and heterologous influenza A viruses in mice.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: